article thumbnail

STAT+: Wyden claims Pfizer used a ‘colossal’ scheme to avoid paying billions in U.S. taxes

STAT

customers six years ago, but did not report any profits from those sales on its 2019 tax returns because all of the income was supposedly earned offshore, according to an investigation by the Democratic staff of the Senate Finance Committee. In what one U.S. for 2018 and 2020.

article thumbnail

Pharmacists in general practice improve prescribing quality, study finds

The Pharmacist

Theresearch, by the University of Manchester, looked at the differences in prescribing indicators in general practices with and without pharmacists between September 2015 and December 2019.

71
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Latest UKHSA figures show rise in both antibiotic use and resistance

The Pharmacist

year-on-year in 2023 and prescribing levels are now in line with those seen in 2019, according to national surveillance data published by the UK Health Security Agency (UKHSA). Antibiotic use rose by 2.4%

111
111
article thumbnail

STAT+: Vida Ventures brings in new leaders after co-founders’ departure

STAT

Kim and Jail have both been with Vida since 2019 and previously worked with Belldegrun at Kite Pharma.   Cohen will steer public market investing — a first for the firm — while Goodman will work on creating and financing private startups. They join Helen Kim and Rajul Jain on the firm’s leadership team.

224
224
article thumbnail

BREAKING: Pharmacy contract negotiations to start 'early in the new year'

The Pharmacist

Contractors in England are currently working under the terms of a contractual framework agreed in 2019, that expired in March this year. Negotiations for the community pharmacy contract in England will not begin until next year, pharmacy minister Stephen Kinnock has confirmed.

article thumbnail

The Benefits of Integrated CDMO Services: Streamlining Drug Development and Manufacturing

Drug Patent Watch

2019, March 14). Accelerate time to market with integrated CRO/CDMO services. Retrieved from [link] Pfizer CentreOne. Three Good Reasons Why an Integrated CDMO Model Offers the Best Route to Success. Retrieved from [link] Pharmoutsourcing. Integrated CDMO and CRO Services Creates Innovation in Early-Stage Drug Development.

article thumbnail

The Great RIF(T): One FDA Division’s Destruction and What it Could Mean for Generic Drugs

FDA Law Blog: Biosimilars

Since 2019, when DPD took over this process, the Division has published more than 600 ANDA withdrawals at the request of generic drug manufacturers. Processing voluntary ANDA withdrawals under 21 C.F.R. 314.150(c). Managing the process of issuing Covered Product Authorizations (CPAs) under the CREATES Act.